Goldman Sachs says in biotech research report that it is more
profitable to kill patients than cure them: 'Is curing patients a
sustainable business model?'
Goldman
Sachs says in biotech research report that it is more profitable to kill
patients than cure them: 'Is curing patients a sustainable business
model?' (web.archive.org)
by weezkitty to news